Scientists from UC Davis Center for Surgical Bioengineering, the MIND Institute and UC Berkeley’s Murthy Lab are developing ...

GlobalData is the parent company of Clinical Trials Arena. "Ocugen sets sights on Phase III after GA gene therapy win" was ...

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to ...

The company has made more than 50 deals for its proprietary technology as it looks forward to a potentially “transformative” ...

Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.

U.K. biotech Ikarovec has teamed up with VectorBuilder to work on an eye disease gene therapy that could be administered in a ...

The new method is designed to focus specifically on pain-related signals, without interfering with normal activity in other ...

"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are ...

The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...

Sarepta Therapeutics Inc. fell Monday after reporting its embattled gene therapy is expected to miss fourth-quarter sales ...